The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Naitik Jariwala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery and Disposition unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000Leuven, Belgium. Hauptthemen laut MEDLINE: Plasticizers, Methylcellulose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: internal funding from the former Division of Virology and Chemotherapy, Rega Institute, KU Leuven, Johnson and Johnson Innovative Medicine, Beerse, Belgium.
Abstract (Originalsprache)
The aim of this study was to gain detailed insights into how different plasticizers influence the permeability of isolated hydroxypropyl methyl cellulose phthalate (HPMC-P) films. Since the migration of plasticizers from film coatings may critically affect their functionality, it is essential to monitor the impact of their leaching on the associated film properties. In this work, the leaching behavior of plasticizers from isolated HPMC-P films was estimated using their thermal properties by modulated temperature differential scanning calorimetry (MT-DSC) at varying plasticizer concentrations. The films plasticized with acetyl triethyl citrate (ATEC) and dibutyl sebacate (DBS) exhibited lower permeability compared to those plasticized with polyethylene glycol 400 (PEG 400). This reduced permeability can be attributed to the slower leaching rates of ATEC and DBS and to the persistent hydrophobic character that they impart to the films, even after prolonged aqueous exposure. In contrast, films plasticized with PEG 400 demonstrated the highest permeability because of the hydrophilicity induced in the polymeric films. However, a subsequent decline in their diffusion rate was observed once PEG 400 had leached out of the films. Furthermore, the correlation between leaching behavior and flux profiles provided an understanding of the influence of plasticizer on film permeability based on their polarity. Moreover, saturation in plasticization efficiency was noted with DBS-based films at higher plasticizer concentrations (greater than 10% w/w). Overall, our study highlights the importance of selecting appropriate plasticizers for the development of polymer films and provides insights into tailoring film permeability and drug release kinetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Delivery and Disposition unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000Leuven, Belgium.
- Molecular Structural and Translational Virology Research Group, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000Leuven, Belgium.
ORCID-Profile: Naitik Jariwala, Samuel De Kerpel, Kurt Vermeire, Guy Van den Mooter
Förderung
- internal funding from the former Division of Virology and Chemotherapy, Rega Institute, KU Leuven
- Johnson and Johnson Innovative Medicine, Beerse, Belgium
Zitieren
APA
Jariwala, N., De Kerpel, S., Provinciael, B., Vermeire, K., & Van den Mooter, G. (2026). The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01573
Vancouver
Jariwala N, De Kerpel S, Provinciael B, Vermeire K, Van den Mooter G. The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01573
BibTeX
@article{Jariwala2026,
author = {Jariwala, Naitik and De Kerpel, Samuel and Provinciael, Becky and Vermeire, Kurt and Van den Mooter, Guy},
title = {The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01573}
}
EUVIMED